Raymond James & Associates Balchem Corp Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Balchem Corp stock. As of the latest transaction made, Raymond James & Associates holds 54,089 shares of BCPC stock, worth $7.82 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

54,089

Previous 50,348 7.43%

Holding current value

$7.82 Million

Previous $7.75 Million 22.75%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$154.1 - $181.56 $576,488 - $679,215	3,741 Added 7.43%	54,089 $9.51 Million
Q2 2024 Jul 19, 2024	BUY	$138.5 - $156.63 $128,389 - $145,196	927 Added 1.88%	50,348 $7.75 Million
Q1 2024 Apr 22, 2024	BUY	$137.06 - $157.27 $1.33 Million - $1.53 Million	9,725 Added 24.5%	49,421 $7.66 Million
Q4 2023 Jan 16, 2024	SELL	$115.08 - $150.35 $266,410 - $348,060	-2,315 Reduced 5.51%	39,696 $5.9 Million
Q3 2023 Oct 24, 2023	SELL	$123.38 - $142.72 $115,853 - $134,014	-939 Reduced 2.19%	42,011 $5.21 Million
Q2 2023 Jul 25, 2023	SELL	$122.28 - $136.64 $109,807 - $122,702	-898 Reduced 2.05%	42,950 $5.79 Million
Q1 2023 Apr 14, 2023	SELL	$117.39 - $142.06 $901,437 - $1.09 Million	-7,679 Reduced 14.9%	43,848 $5.55 Million
Q4 2022 Feb 08, 2023	BUY	$120.16 - $142.73 $228,424 - $271,329	1,901 Added 3.83%	51,527 $6.29 Million
Q3 2022 Oct 25, 2022	BUY	$119.7 - $141.48 $968,492 - $1.14 Million	8,091 Added 19.48%	49,626 $6.03 Million
Q2 2022 Aug 12, 2022	BUY	$113.6 - $139.82 $232,425 - $286,071	2,046 Added 5.18%	41,535 $5.39 Million
Q1 2022 May 11, 2022	BUY	$131.21 - $167.55 $165,455 - $211,280	1,261 Added 3.3%	39,489 $5.4 Million
Q4 2021 Feb 08, 2022	BUY	$149.18 - $172.5 $62,953 - $72,795	422 Added 1.12%	38,228 $6.45 Million
Q3 2021 Nov 02, 2021	BUY	$129.2 - $150.61 $319,253 - $372,157	2,471 Added 6.99%	37,806 $5.49 Million
Q2 2021 Aug 11, 2021	BUY	$119.87 - $133.92 $45,071 - $50,353	376 Added 1.08%	35,335 $4.64 Million
Q1 2021 May 14, 2021	SELL	$107.03 - $131.53 $168,144 - $206,633	-1,571 Reduced 4.3%	34,959 $4.38 Million
Q4 2020 Feb 12, 2021	BUY	$98.58 - $115.22 $119,873 - $140,107	1,216 Added 3.44%	36,530 $4.21 Million
Q3 2020 Nov 04, 2020	BUY	$91.61 - $103.46 $989,296 - $1.12 Million	10,799 Added 44.05%	35,314 $3.45 Million
Q2 2020 Jul 28, 2020	BUY	$80.3 - $102.54 $1.02 Million - $1.3 Million	12,694 Added 107.39%	24,515 $2.33 Million
Q1 2020 Apr 21, 2020	SELL	$81.49 - $113.6 $114,167 - $159,153	-1,401 Reduced 10.6%	11,821 $1.17 Million
Q4 2019 Feb 12, 2020	BUY	$96.34 - $105.25 $150,675 - $164,611	1,564 Added 13.42%	13,222 $1.34 Million
Q3 2019 Nov 07, 2019	BUY	$83.01 - $105.34 $5,395 - $6,847	65 Added 0.56%	11,658 $1.16 Million
Q2 2019 Aug 06, 2019	BUY	$90.69 - $102.96 $15,870 - $18,018	175 Added 1.53%	11,593 $1.16 Million
Q1 2019 May 06, 2019	SELL	$76.21 - $95.45 $9,602 - $12,026	-126 Reduced 1.09%	11,418 $1.06 Million
Q4 2018 Feb 11, 2019	SELL	$73.39 - $110.81 $293 - $443	-4 Reduced 0.03%	11,544 $904,000
Q3 2018 Nov 14, 2018	SELL	$97.22 - $116.69 $2.55 Million - $3.06 Million	-26,231 Reduced 69.43%	11,548 $1.29 Million
Q2 2018 Aug 14, 2018	SELL	$80.7 - $100.4 $104,667 - $130,218	-1,297 Reduced 3.32%	37,779 $3.71 Million
Q1 2018 May 14, 2018	SELL	$70.84 - $82.37 $58,513 - $68,037	-826 Reduced 2.07%	39,076 $3.19 Million
Q4 2017 Feb 14, 2018	BUY	$79.39 - $87.71 $81,612 - $90,165	1,028 Added 2.64%	39,902 $3.22 Million
Q3 2017 Nov 13, 2017	BUY	$73.12 - $81.91 $5,922 - $6,634	81 Added 0.21%	38,874 $3.16 Million
Q2 2017 Aug 14, 2017	BUY	N/A	38,793	38,793 $3.02 Million

Others Institutions Holding BCPC

# of Institutions

423

Shares Held

28.9M

Call Options Held

64.8K

Put Options Held

6.2K

View Full List

About BALCHEM CORP

Ticker BCPC
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 32,120,600
Market Cap $4.65B
Description
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal N...

More about BCPC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Balchem Corp Transaction History